
Connect With WCG at Booth 1513
Join WCG at the DIA 2025 conference in Washington, D.C., from June 15-19, as we showcase our connected solutions that enhance collaboration, efficiency, and innovation to drive your research to results.
As a trusted partner for tackling the industry’s challenges efficiently and intelligently, our integrated solutions, powered by the cutting-edge technology platform, ClinSphere™, offer:
- Study Planning & Review: Solutions to architect the design and review of clinical studies to protect participants and select the most optimal sites.
- Site & Study Enablement: Holistic solutions for sites and studies to optimize operations from study start-up to closeout.
- Data & Insights: Strategic decision-making and innovation driven by clinical trial data paired with expert consulting services.
Why partner with WCG?
- Unrivaled data set: Utilize the industry’s most comprehensive data to make informed decisions and accelerate the transition from research to results.
- Global reach: Therapeutic experts spread across 130 countries, our global team merges expertise with data to enhance the efficiency and effectiveness of your research.
- Innovation in every decision: Leverage advanced technology and solutions to drive your trials toward faster, smarter outcomes.
We are excited to explore partnerships that can drive research to results more quickly while safeguarding participant safety and clinical trial data.
Visit us at Booth #1513 or contact us in advance to schedule a meeting during the conference.
WCG Sessions at DIA
Monday, June 16, 2:15-3:15 pm
Clinical Care vs. Research: Walking the Ethical Tightrope Between Advocacy and Coercion
This session will delve into the historical and ethical context for distinguishing between clinical care and research and how the blurring poses a risk for engagement with patients. Experts in ethics and health literacy will discuss potential pitfall.
WCG Speaker
Tuesday, June 17, 4-5 pm
Using Generative AI to Explore our Track Record on Paying Participants: What Can We Learn to Support More Diverse Representation
This session will present trends and insights from an analysis of participant payment language of more than 7,500 consent forms reviewed by a large, independent IRB and discuss the ethical implications of insufficient compensation for trial participants.